Shalby Limited
Shalby Limited scores highest on Price (78) and lowest on Nitro (4). Its PosiPenta is 37.71 out of 100, weaker than most similar companies.
On the Penta Grid this week, Shalby Limited is Grid #140 of 165 in the Healthcare sector in India, and Grid #1,856 of 2,329 in India.
Compared with similar companies in the Healthcare sector in India.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Shalby Limited | 37.71 | 78 | 53 | 4 | 14 | 40 |
| Bharat Parenterals Limited | 26.52 | 31 | 0 | 52 | 11 | 38 |
| Kopran Limited | 47.08 | 56 | 18 | 94 | 28 | 40 |
| Anlon Healthcare Limited | 37.44 | 40 | 14 | 45 | 57 | 32 |
| Fermenta Biotech Limited | 60.03 | 71 | 64 | 70 | 49 | 46 |
| 3B Blackbio Dx Limited | 66.69 | 71 | 87 | 55 | 80 | 40 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | 31.39 |
| P/B ratio | 1.23 |
EEarnings
| Trailing EPS | ₹3.67 |
| Forward EPS | ₹9.40 |
NNitro
| Price | 115.19 |
| 52-week high | 254.95 |
| 52-week low | 115.19 |
| Fall from 52-week high | 54.8% |
TTorque
| Return on equity (ROE) (calculated) | 3.93% |
| Debt-to-equity | 0.59 |
AAnchor
| Beta (price swings) | 0.61 |
| Market cap | ₹1,238 Cr |
| Promoter holding | 74.33% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Shalby Limited's PosiPenta score?
Shalby Limited's PosiPenta is 37.71 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Shalby Limited stand on the Penta Grid?
On the Penta Grid this week, Shalby Limited is Grid #140 of 165 in the Healthcare sector in India, and Grid #1,856 of 2,329 in India.
Which PosiPenta pillar is strongest for Shalby Limited?
Price (valuation), with a score of 78 out of 100: better than most similar companies.
Which PosiPenta pillar is weakest for Shalby Limited?
Nitro (momentum), with a score of 4 out of 100: much weaker than most similar companies.
PositoAI is for research and education only and is not investment advice.